Statistics
Publications
18
Citations
937
H-Index
15
Active since
2000
Hongliang Dou is an author at Peking University Third Hospital specializing in medicine, ophthalmology, and macular disease.
Publications per year
2000–2024
18
18
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression
Michael Elkin, Hua‐Quan Miao, Arnon Nagler et al. · The FASEB Journal · 2000 · 103 citations
Medicine, Oncology, Pharmacology +15
Le Ma, Hongliang Dou, Yangmu Huang et al. · American Journal of Ophthalmology · 2012 · 84 citations
Yangmu Huang, Hongliang Dou, Feifei Huang et al. · BioMed Research International · 2015 · 79 citations · Full text
1–5 of 18